by Claudia Li | Mar 11, 2024 | Press Releases
Press release Florida Selects DiaCarta’s cfDNA Test (RadTox™) for Statewide Use to Detect Early Response of Cancer Treatment FollowFollow DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly...
by Claudia Li | Mar 4, 2024 | Press Releases
Press release DiaCarta Announces That the Oncuria® Bladder Cancer Tests Receive Medicare Coverage Effective January 1, 2024 FollowFollow DiaCarta proudly announced that the Oncuria® Bladder Cancer Tests, developed by Nonagen Bioscience and validated by DiaCarta as a...
Recent Comments